accountAfter Merck's acquisition, the two decided to give it another go, joining Merial and Intervet to surpass Pfizer (NYSE:...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
PFIZER
Pfizer, Inc. is the world’s largest pharmaceutical company in the world, by sales. The New York-based company produces the No. 1-selling drug, along with other widely used prescription drugs as Lipitor, Lyriuca, Diflucan, Celebrex and Viagra. This topic covers the latest news on Pfizer.
Pfizer is part of Business Exchange, suggested by
Maki Yamasaki.
This topic contains
1,236 news
and
381 blog
items.
Read updated news, blogs, and resources about Pfizer. Find user-submitted articles and reactions on Pfizer from
like-minded professionals.
News
Please add new articles to this topic
Administration, seeking to block India���s Ranbaxy Laboratories Ltd.���s exclusive rights to sell a generic version of...
generic-drug maker Mylan has sued the FDA in a bid to allow the introduction of copycat versions of Pfizer's popular...
the U.S. Daiichi is also preparing for its exclusive U.S. launch of a generic version of Pfizer Inc.'s cholesterol...
their animal health businesses. The linking of Sanofi���s Merial with Merck���s Intervet business would have surpassed...
resolve antitrust concerns, two people with knowledge of the matter said in October. Prospective buyers may have...
Administration, seeking to block India���s Ranbaxy Laboratories Ltd.���s exclusive rights to sell a generic version of...
billion market, is projected to grow at about a 5% annual rate, making it an attractive business for Pfizer and Lilly...
the U.S. Food and Drug Administration in an effort to allow the introduction of generic versions of Pfizer Inc.
Sanofi's pet-focused Merial unit, which they once jointly owned, with Merck's bigger, livestock-oriented Intervet...
Ranbaxy is the first generic company to get approval from the USFDA to sell the generic version of Pfizer's Lipitor,...
market last week. The loan is expected to be the second-largest bridge loan in the U.S. after Pfizer's $22.
14) in patients with diabetic macular edema (DME). PF-04523655 incorporates Silence's AtuRNAi technology and was...
The $20 billion commitment ranks as the no. 2 bridge loan offered worldwide since 2000, second only to Pfizer���s $22.
Shares? The Bankers You Hire to Sell to Warren Buffett? Meet the Stealth Adviser on the GM IPO Pfizer: $68 Billion and...
Mylan Inc (MYL.O) has sued the U.S. Food and Drug Administration to get generic versions of Pfizer Inc's (PFE.
The $20 billion bridge loan JP Morgan provided to AT&T in order to help cement its planned purchase of Deutsche...
U.S. drug regulator in an attempt to block Ranbaxy's impending launch of a generic version of Pfizer's cholesterol drug...
court against the FDA, asking the agency to bar Ranbaxy Laboratories from exclusively selling a generic version of...
for repatriation relief includes Adobe (ADBE), Apple, CA Technologies (CA), Duke Energy (DUK), Google, Microsoft...
the Obama administration, but they are still considered solid defensive stocks. During recent selloffs, Merck (MRK),...
companies of products for infant and children's nutrition. It was spun out of Bristol-Myers Squibb (NYSE: BMY Pfizer...
European drugs regulators said on Friday they were recommending Pfizer's (PFE.N) and Bristol Myers Squibb's (BMY.
YORK, March 18 (Reuters Health) - When the U.S. Food and Drug Administration announced in 2009 that Pfizer Inc's (PFE.
disease drugs are the biggest losers in the delay bringing Amyvid to market. Forest Labs' (NYSE: FRX ) Namenda, Pfizer...
Top Sources: Pfizer
- blogs.barrons.com
- BusinessWeek
- knowledge.wharton.upenn.edu
- online.wsj.com
- MarketWatch
- SeekingAlpha.com
- TheStreet.com
- Forbes.com
- startribune.com
- clinicaspace.com
Post a Job
Jobs in this Topic
NCBiotech Industrial Fellowship - Icagen, Inc. (Pfizer)
North Carolina Biotechnology Center
|
Durham, NC
Posted: Apr 10